PD‐L1 expression on CTCs was first demonstrated in breast cancer,17 and then reported in colorectal cancer, bladder cancer, NSCLC, HNSCC, and melanoma.18, 19, 20, 21, 22. This evidence concerns the gene CD274 and breast carcinoma.